Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Leveling the Playing Field: A Guide to Successful Business Development Transactions for Private and Small Public Life Science Companies

Leveling the Playing Field: A Guide to Successful Business Development Transactions for Private and Small Public Life Science Companies

Scott, Jane V.
Horowitz, Lawrence P.
Ellberger, Larry

Paperback

Business General

Publisher Price: $16.95

ISBN10: 0595517005
ISBN13: 9780595517008
Publisher: Authorhouse
Published: Dec 2 2008
Pages: 172
Weight: 0.57
Height: 0.40 Width: 6.00 Depth: 9.00
Language: English
Business development transactions are an important way for private and small cap life science companies to realize value. When negotiating transaction terms, small companies confront a playing field tilted steeply to the advantage of large companies such as Pfizer, GSK, J&J, and Medtronic. Leveling the Playing Field shows how small companies can create a level playing field and achieve a transaction that fully recognizes the value of their technologies and products.

Leveling the Playing Field uses auctions as a model for successful business development. Auctions are especially effective in creating power for sellers when many, wealthy bidders compete enthusiastically to acquire a singular asset, a Rembrandt painting, a uniquely situated piece of real estate, a small company's technology or product. Leveling the Playing Field guides small companies through the process of attracting large companies, transforming their interest into enthusiasm, and maintaining a high level of competition among potential buyers for as long as possible.

Leveling the Playing Field draws on the authors' experiences closing more than 100 transactions ranging in size from a few million to over $2 billion as well as their serving as senior finance, R&D, and operations executives with large and small life science companies.

Also in

Business General

View All